Study identifies new therapeutic candidate for KRAS-driven pancreatic cancer
View as a Web Page
News Medical
 
  Hepatology Hepatology logo  
  The latest hepatology news from News Medical  
 Weight loss medications show promise in preventing obesity-related cancersWeight loss medications show promise in preventing obesity-related cancers
 
A study of more than 229,000 obese adults without diabetes in the United States has shown that weight loss drugs are associated with a decreased risk of obesity-related cancers.
 
 
 Study identifies new therapeutic candidate for KRAS-driven pancreatic cancerStudy identifies new therapeutic candidate for KRAS-driven pancreatic cancer
 
A new research paper was published in Volume 17 of Oncotarget on June 3, 2026, titled "The anticancer effects of PCAIs in pancreatic cancer cells involve MAPK and PI3K/AKT pathways hyperactivation."
 
   New protocol prevents heavy alcohol relapse after liver transplantationNew protocol prevents heavy alcohol relapse after liver transplantation
 
In a study published in the Liver Transplantation journal by the American Association for the Study of Liver Diseases, Mayo Clinic researchers found that a new proactive treatment protocol for alcohol use disorder after liver transplant resulted in a 0% heavy alcohol relapse rate among patients who followed the protocol, compared with a historical relapse rate of approximately 25%.
 
   Engineered Salmonella delivers cancer-fighting viruses to deep tumorsEngineered Salmonella delivers cancer-fighting viruses to deep tumors
 
Researchers at the University of Massachusetts Amherst have designed non-toxic Salmonella bacteria to deliver viruses that are safe to humans but potent against liver and pancreatic cancer tumors - two cancers with an extremely poor prognosis.
 
   Amplified Sciences secures investment for pancreatic cyst diagnostic assayAmplified Sciences secures investment for pancreatic cyst diagnostic assay
 
Amplified Sciences, a clinical-stage diagnostics company pioneering next-generation multi-omic assays, today announced a new investment from the American Gastroenterological Association's (AGA) GI Opportunity Fund as part of its recent Seed+ financing round.
 
 Organ transplant survival rates improve despite persistent donor shortages
 
More adults are surviving both the wait for an organ and transplant surgery, but the number of people who need transplants continues to exceed the number of organs available, especially for kidneys, according to a national analysis published in the Journal of the American College of Surgeons (JACS).
 
 
 Cellular map of healthy pancreas reveals origins of deadly tumors
 
Scientists at the Free University of Brussels (VUB) have taken a major step forward in pancreatic cancer research. By mapping a healthy pancreas in detail down to the cellular level, they discovered that specific, rare cells in the healthy organ already bear strong similarities to the most aggressive tumor cells.
 
 
 New technique protects pancreatic islet transplants without immunosuppressive drugs
 
Type 1 diabetes (T1D) is a lifelong autoimmune disorder where the immune system attacks islets, certain areas of the pancreas, and destroys cells that would otherwise produce insulin, a hormone crucial for regulating blood sugar levels.
 
 
 Review highlights TIGIT as a promising second-generation immunotherapy target
 
Malignant tumors remain a major threat to human health, with conventional therapies and first-generation immune checkpoint inhibitors (ICIs) facing limitations like drug resistance and low response rates.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026